Pricing Log in Create free account

EyePoint, Inc. (EYPT) vs Fulcrum Therapeutics, Inc. (FULC)

EyePoint, Inc. and Fulcrum Therapeutics, Inc. are both Biotechnology companies. EyePoint, Inc. and Fulcrum Therapeutics, Inc. are of similar size ($280.0M and $270.7M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against −94.6%. Fulcrum Therapeutics, Inc. has the higher net margin (0.00% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Fulcrum Therapeutics, Inc. leads on 13 and EyePoint, Inc. on 2.

Valuation

Metric EYPT FULC Biotechnology median
P/E n/m n/m 8.50
P/S 93.12 3.37 9.71
P/B 1.56 0.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.43 0.64
EV/Sales 40.83 (0.49) 9.21
Earnings yield (124.67%) (33.15%) (33.15%)
Free cash flow yield (104.43%) (23.60%) (25.50%)

Profitability

Metric EYPT FULC Biotechnology median
Gross margin 41.75% 100.00% 65.16%
Operating margin (11,369.30%) 0.00% 0.00%
Net margin (10,998.67%) 0.00% 0.00%
Free cash flow margin (9,724.68%) 0.00% 0.00%
Return on equity (148.70%) (32.38%) (56.36%)
Return on assets (115.86%) (30.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EYPT FULC Biotechnology median
Revenue growth (TTM) (94.63%) 1,939.80% 6.02%
EPS growth (last fiscal year) (36.64%) (637.50%) 30.26%
Revenue growth, 5-year CAGR (1.85%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EYPT FULC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.50 31.35 4.72
Net debt to EBITDA 1.24 4.23 0.96

Dividend

Metric EYPT FULC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EYPT FULC Biotechnology median
Market cap 270.71m 280.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack